Below are the most recent publications written about "Adenocarcinoma" by people in Profiles.
-
Canto MI, Trindade AJ, Abrams J, Rosenblum M, Dumot J, Chak A, Iyer P, Diehl D, Khara HS, Corbett FS, McKinley M, Shin EJ, Waxman I, Infantolino A, Tofani C, Samarasena J, Chang K, Wang B, Goldblum J, Voltaggio L, Montgomery E, Lightdale CJ, Shaheen NJ. Multifocal Cryoballoon Ablation for Eradication of Barrett's Esophagus-Related Neoplasia: A Prospective Multicenter Clinical Trial. Am J Gastroenterol. 2020 11; 115(11):1879-1890.
-
Zhang L, Cai Z, Ambelil M, Conyers J, Zhu H. Mesonephric Adenocarcinoma of the Uterine Corpus: Report of 2 Cases and Review of the Literature. Int J Gynecol Pathol. 2019 May; 38(3):224-229.
-
Barel F, Auffret A, Cariou M, Kermarrec T, Samaison L, Bourhis A, Badic B, Jézéquel J, Cholet F, Bail JP, Marcorelles P, Nousbaum JB, Robaszkiewicz M, Doucet L, Uguen A. High reproducibility is attainable in assessing histoprognostic parameters of pT1 colorectal cancer using routine histopathology slides and immunohistochemistry analyses. Pathology. 2019 Jan; 51(1):46-54.
-
Fong LY, Jing R, Smalley KJ, Wang ZX, Taccioli C, Fan S, Chen H, Alder H, Huebner K, Farber JL, Fiehn O, Croce CM. Human-like hyperplastic prostate with low ZIP1 induced solely by Zn deficiency in rats. Proc Natl Acad Sci U S A. 2018 11 20; 115(47):E11091-E11100.
-
Minion LE, Tewari KS. Cervical cancer - State of the science: From angiogenesis blockade to checkpoint inhibition. Gynecol Oncol. 2018 03; 148(3):609-621.
-
Tarhini AA, Rafique I, Floros T, Tran P, Gooding WE, Villaruz LC, Burns TF, Friedland DM, Petro DP, Farooqui M, Gomez-Garcia J, Gaither-Davis A, Dacic S, Argiris A, Socinski MA, Stabile LP, Siegfried JM. Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer. Cancer. 2017 Aug 01; 123(15):2936-2944.
-
Schrock AB, Li SD, Frampton GM, Suh J, Braun E, Mehra R, Buck SC, Bufill JA, Peled N, Karim NA, Hsieh KC, Doria M, Knost J, Chen R, Ou SI, Ross JS, Stephens PJ, Fishkin P, Miller VA, Ali SM, Halmos B, Liu JJ. Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling. J Thorac Oncol. 2017 06; 12(6):932-942.
-
Pishvaian MJ, Brody JR. Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer. Oncology (Williston Park). 2017 Mar 15; 31(3):159-66, 168.
-
Selby LV, DeMatteo RP, Tholey RM, Jarnagin WR, Garcia-Aguilar J, Strombom PD, Allen PJ, Kingham TP, Weiser MR, Brennan MF, Strong VE. Evolving application of minimally invasive cancer operations at a tertiary cancer center. J Surg Oncol. 2017 Mar; 115(4):365-370.
-
Pishvaian MJ, Biankin AV, Bailey P, Chang DK, Laheru D, Wolfgang CL, Brody JR. BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer. Br J Cancer. 2017 Apr 11; 116(8):1021-1026.